Predictive Value of EGFR Mutation Status for First-Line Tyrosine Kinase Inhibitor Treatment in Patients with Advanced Lung Cancer.

Autor: Youqin Xie1, Jinliang Chen1, Wen Zhu1, Zhihui Ye, Xuedong Lv1 ntyyxd123@163.com
Zdroj: Alternative Therapies in Health & Medicine. Aug2024, Vol. 30 Issue 8, p295-299. 5p.
Databáze: Academic Search Ultimate